Home›Companies›Biotech & Pharma›Ophthalmic Therapeutic Innovation

Ophthalmic Therapeutic Innovation LLC

Updated Oct 29, 2026·Latest SEC filing Dec 2, 2025·Suggest an edit

About Ophthalmic Therapeutic Innovation

Ophthalmic Therapeutic Innovation is a private company based in Watertown, Massachusetts, incorporated in 2023 in Massachusetts. It has reported $100,000 raised in one offering on Form D since December 2025. Its chief executive is Guanting Qiu.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 8, 2025Dec 2, 2025$100,000of $300K target2$50,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ophthalmic Therapeutic Innovation's Form D filed Dec 2, 2025.

GQ
Guanting Qiu
OTI's Founder and CEO

Sources

  1. SECOphthalmic Therapeutic Innovation LLC filing history